The present invention relates to : * combinations of : component A : one or more omega-carboxyaryl-substituted diphenyl urea compounds of general formula (I), or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof； component B : one or more N-(2-arylamino) aryl sulfonamide compounds of general formula (II), or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof； and, optionally, component C : one or more further pharmaceutical agents； in which optionally some or all of the components are in the form of a pharmaceutical formulation which is ready for use to be administered simultaneously, concurrently, separately or sequentially. dependently of one another by the oral, intravenous, topical, local installations, intraperitoneal or nasal route； * use of such combinations for the preparation of a medicament for the treatment or prophylaxis of a cancer； and * a kit comprising such a combination.
